
Stephen John Greene MD
Adult Congenital Heart Disease, Heart Failure & Transplantation
Physician
Join to view full profile
2301 Erwin Rd # Dumc3845Durham, NC 27705
Phone+1 919-684-8111
Dr. Greene is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Cardiovascular Disease, 2015 - 2017
Northwestern University The Feinberg School of MedicineClass of 2012
Certifications & Licensure
NC State Medical License 2015 - 2027
IL State Medical License 2012 - 2015
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019 Start of enrollment: 2021 Aug 06
Publications & Presentations
PubMed
- Comparative effectiveness of torsemide vs furosemide in the management of heart failure patients: Win-ratio reanalysis of the TRANSFORM-HF trial.Guangyu Tong, Yukang Zeng, Stephen J Greene, Kevin J Anstrom, Jeffrey Testani
American Heart Journal. 2026-11-01 - Initial Diuretic Strategy During Hospitalization for Heart Failure and Associated Outcomes: Insights from the TREAT-AHF Registry.Anubodh S Varshney, Andrew P Ambrosy, Adam Furst, Jimmy Zheng, Ankeet S Bhatt
Journal of Cardiac Failure. 2026-08-10 - Contemporary medical therapy for heart failure with mildly reduced or preserved ejection fraction.Craig J Beavers, Stephen J Greene
Heart Failure Reviews. 2026-08-07
Press Mentions
AHA Heart Failure Registry Making a Major Impact After 20 YearsJuly 30th, 2026
Reduced Mortality May Offset Hyperkalemia Risk with Optimal RAS Inhibitor, MRA Therapy for Heart FailureOctober 3rd, 2025
Study Finds Shortening Vericiguat Ramp up to Target Dose in HFrEF from Two to One Steps Is SafeJune 12th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









